innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Hub4aim has an unique proposal to manage the preindustrial
phase from the proof of concept to regulatory marking.
Iprasense has just released its third product, one that leverages a lensless imaging technology protected by around a dozen patents. The company’s latest offering is particularly well-suited for high-throughput cellular screening in drug discovery.
GRENOBLE, France & LOS ANGELES – May 3, 2018 – Leti, a research institute at CEA Tech, and Cellmic LLC, a company dedicated to improving patient healthcare with smartphones and biophotonics, today announced that they joined forces to accelerate the market adoption of lens-free imaging and sensing techniques by growing Leti’s patent portfolio with a core patent from Cellmic.
CEA-Leti, a CEA microelectronics research institute, will introduce a smart, integrated multi-sensor system for knee implants at CES 2022 that can help surgeons more accurately position the implant, dramatically reduce risk of follow-up surgery, and enhance rehabilitation.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.